ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TBIO Telesis Bio Inc

0.435
-0.015 (-3.33%)
Pre Market
Last Updated: 06:32:11
Delayed by 15 minutes

Period:

Draw Mode:

Volume 355
Bid Price 0.3715
Ask Price 0.54
News -
Day High

Low
0.30

52 Week Range

High
3.3199

Day Low
Company Name Stock Ticker Symbol Market Type
Telesis Bio Inc TBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.015 -3.33% 0.435 06:32:11
Open Price Low Price High Price Close Price Prev Close
0.45
Trades Volume Avg Volume 52 Week Range
3 355 - 0.30 - 3.3199
Last Trade Time Type Quantity Stock Price Currency
06:32:11 59 $ 0.435 USD

Telesis Bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
13.49M 29.98M - 27.44M -48.47M -1.62 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Telesis Bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TBIO Message Board. Create One! See More Posts on TBIO Message Board See More Message Board Posts

Historical TBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.44940.490.390.452537675,307-0.0144-3.20%
1 Month0.53880.58990.36010.5049846142,864-0.1038-19.27%
3 Months0.38810.8590.3010.6112883805,0250.046912.08%
6 Months1.061.170.300.5636391500,622-0.625-58.96%
1 Year2.853.31990.300.7219167284,226-2.42-84.74%
3 Years16.4037.9850.3023.34713,889-15.97-97.35%
5 Years9.3037.9850.3020.00747,425-8.87-95.32%

Telesis Bio Description

Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of virtually error-free DNA and mRNA at a useable scale. Its on-market and planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp DBC, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, BioXp DBC kits, Benchtop reagents and Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS). BioXp 3250 system is a push-button, walkaway, end-to-end automated workstation that offers endpoint-ready synthetic DNA in as few as 8 hours and mRNA in less than 24 hours. BioXp DBC is engaged in delivering on-demand enzymatic DNA synthesis with design-to-endpoint-ready synthetic RNA in as few as 24 hours.

Your Recent History

Delayed Upgrade Clock